Medipharm Labs Earnings Estimate

LABS Stock  CAD 0.07  0.01  7.14%   
By analyzing Medipharm Labs' earnings estimates, investors can diagnose different trends across Medipharm Labs' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Medipharm Labs Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Medipharm Labs is projected to generate 0.0 in earnings per share on the 31st of December 2024. Medipharm Labs earnings estimates show analyst consensus about projected Medipharm Labs Corp EPS (Earning Per Share). It derives the highest and the lowest estimates based on Medipharm Labs' historical volatility. Many public companies, such as Medipharm Labs, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Medipharm Labs' earnings estimates, investors can diagnose different trends across Medipharm Labs' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Medipharm Labs' Gross Profit is very stable compared to the past year. As of the 13th of December 2024, Gross Profit Margin is likely to grow to 0.19, while Pretax Profit Margin is likely to drop (0.42).
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medipharm Labs Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Medipharm Labs Earnings per Share Projection vs Actual

About Medipharm Labs Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Medipharm Labs earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Medipharm Labs estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Medipharm Labs fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-176.7 M-167.9 M
Earnings Yield(0.55)(0.58)
Price Earnings Ratio(1.81)(1.71)
Price Earnings To Growth Ratio 0.03  0.03 

Pair Trading with Medipharm Labs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medipharm Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Medipharm Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medipharm Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medipharm Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medipharm Labs Corp to buy it.
The correlation of Medipharm Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medipharm Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medipharm Labs Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medipharm Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Medipharm Stock

Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.